Triple Hair
Triple Hair
  • Publications
  • Contact
  • FR
  • Products
    • PRESCRIPTION
      • Therapy-07
    • DRUG-FREE
      • Therapy-16
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials
  • Products
    • PRESCRIPTION l Therapy-7
    • DRUG-FREE l Therapy-16
    • Hair Loss Rx Consult
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials

About: Jean-Philippe Gravel

Posts by Jean-Philippe Gravel:

  • Triple Hair Group announces strategic arrangement with leading US compounding company Pharmacy SolutionsPosted on June 21, 2022 (June 28, 2022) by Jean-Philippe GravelinCorporate
  • Triple Hair Group announces the launch of Plenty Natural™Posted on March 24, 2022 (April 14, 2022) by Jean-Philippe GravelinCorporate
  • Triple Hair Group announces the launch of RIZN™Posted on December 7, 2021 (December 7, 2021) by Jean-Philippe GravelinCorporate
  • Triple Hair Group adds further expertise to boardPosted on November 29, 2021 (December 7, 2021) by Jean-Philippe GravelinCorporate
  • Q4 2021 Investors NewsPosted on October 14, 2021 (October 15, 2021) by Jean-Philippe GravelinCorporate
  • BIO Digital Start-Up Stadium Finalist and FinancingPosted on May 21, 2020 (June 23, 2020) by Jean-Philippe GravelinCorporate
  • Triple Hair retains EndoceuticsPosted on April 16, 2020 (June 23, 2020) by Jean-Philippe GravelinScience
  • Corporate updatePosted on March 26, 2020 (June 23, 2020) by Jean-Philippe GravelinCorporate
  • VP Business Development AppointmentPosted on February 13, 2020 (June 23, 2020) by Jean-Philippe GravelinCorporate
  • Chief Scientific Officer AppointmentPosted on February 5, 2020 (June 23, 2020) by Jean-Philippe GravelinCorporate

Posts navigation

  • 1
  • 2
  • »

Search

Recent Posts

  • TH07 Clinical Study Featured in Peer-Reviewed Scientific Journal
  • Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India
  • Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe
  • Triple Hair’s Feature in Le Journal de Montréal
  • Triple Hair Group Closes $4 Million Financing

Recent Comments

    Triple Hair is a clinical-stage Canadian
    biotechnology company specialized in the
    development of innovative treatments for alopecia.

    Revolutionary
    hair growth
    therapies

    • Company
    • Products
    • Therapy-07
    • Science
    • Contact
    • Therapy-16
    • Investors
    • Terms and Conditions
    • Privacy Policy

    Copyright © 2020 | Triple Hair

    Clinical Trials
    Looking to invest?